Can-Fite BioPharma Ltd. (IL:CANF)
TASE:CANF
Total Valuation
Can Fite Bio has a market cap or net worth of ₪21.90M. The enterprise value is 8.52B.
Market Cap₪21.90M
Enterprise Value8.52B
Share Statistics
Can Fite Bio has 4,285,093 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,285,093
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Can Fite Bio’s return on equity (ROE) is -1.90 and return on invested capital (ROIC) is -157.46%.
Return on Equity (ROE)-1.90
Return on Assets (ROA)-1.12
Return on Invested Capital (ROIC)-157.46%
Return on Capital Employed (ROCE)-1.59
Revenue Per Employee87.68K
Profits Per Employee-2.13M
Employee Count5
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Can Fite Bio is ―. Can Fite Bio’s PEG ratio is >-0.00001.
PE Ratio―
PS Ratio35.39
PB Ratio2.77
Price to Fair Value2.77
Price to FCF-1.60
Price to Operating Cash Flow-680.74
PEG Ratio>-0.00001
Income Statement
In the last 12 months, Can Fite Bio had revenue of 438.40K and earned -10.64M in profits. Earnings per share was -6.46.
Revenue438.40K
Gross Profit412.42K
Operating Income-10.77M
Pretax Income-10.64M
Net Income-10.64M
EBITDA-10.74M
Earnings Per Share (EPS)-6.46
Cash Flow
In the last 12 months, operating cash flow was -8.35M and capital expenditures -2.00K, giving a free cash flow of -8.36M billion.
Operating Cash Flow-8.35M
Free Cash Flow-8.36M
Free Cash Flow per Share-1.95
Dividends & Yields
Can Fite Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.46
52-Week Price Change27436.84%
50-Day Moving Average668.82
200-Day Moving Average2.47K
Relative Strength Index (RSI)40.16
Average Volume (3m)1.04M
Important Dates
Can Fite Bio upcoming earnings date is Aug 27, 2026, Before Open (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
Can Fite Bio as a current ratio of 3.46, with Debt / Equity ratio of 2.15%
Current Ratio3.46
Quick Ratio3.46
Debt to Market Cap<0.01
Net Debt to EBITDA0.51
Interest Coverage Ratio-710.74
Taxes
In the past 12 months, Can Fite Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Can Fite Bio EV to EBITDA ratio is -0.94, with an EV/FCF ratio of -1.04.
EV to Sales22.94
EV to EBITDA-0.94
EV to Free Cash Flow-1.04
EV to Operating Cash Flow-1.04
Balance Sheet
Can Fite Bio has ₪6.46M in cash and marketable securities with ₪90.00K in debt, giving a net cash position of ₪6.37M billion.
Cash & Marketable Securities₪6.46M
Total Debt₪90.00K
Net Cash₪6.37M
Net Cash Per Share₪1.49
Tangible Book Value Per Share₪3.39
Margins
Gross margin is 100.00%, with operating margin of -2456.79%, and net profit margin of -2426.67%.
Gross Margin100.00%
Operating Margin-2456.79%
Pretax Margin-2426.67%
Net Profit Margin-2426.67%
EBITDA Margin-2450.87%
EBIT Margin-2456.79%
Analyst Forecast
The average price target for Can Fite Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―